Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Niza M. Silungwe"'
Autor:
Alexander J. Stockdale, Niza M. Silungwe, Isaac Thom Shawa, Benno Kreuels, Melita A. Gordon, Anna Maria Geretti
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The World Health Organization (WHO) has targeted a reduction in viral hepatitis-related mortality by 65% and incidence by 90% by 2030, necessitating enhanced hepatitis B treatment and prevention programmes in low- and middle-incom
Externí odkaz:
https://doaj.org/article/0f2fe286896f4308ba8d1d24955d765d
Autor:
Alexander J. Stockdale, Benno Kreuels, Isaac T. Shawa, James E. Meiring, Deus Thindwa, Niza M. Silungwe, Karen Chetcuti, Elizabeth Joekes, Maurice Mbewe, Blessings Mbale, Pratiksha Patel, Rabson Kachala, Priyanka D. Patel, Jane Malewa, Peter Finch, Chris Davis, Rajiv Shah, Lily Tong, Ana Silva Filipe, Emma C. Thomson, Anna Maria Geretti, Melita A. Gordon
Publikováno v:
Journal of viral hepatitis. 29(4)
Hepatitis C virus (HCV) is a leading cause of liver disease worldwide. There are no previous representative community HCV prevalence studies from Southern Africa, and limited genotypic data. Epidemiological data are required to inform an effective pu
Autor:
Deus Thindwa, Alexander J. Stockdale, Maurice Mbewe, Naor Bar-Zeev, Niza M Silungwe, Benno Kreuels, Anna Maria Geretti, Isaac Thom Shawa, James E Meiring, Priyanka Patel, Melita A. Gordon, Pratiksha Patel, Stephen B. Gordon, Marc Y R Henrion, Robert S. Heyderman, Todd D. Swarthout, Rabson Kachala
Publikováno v:
JOURNAL OF INFECTIOUS DISEASES
Background Hepatitis B is the leading cause of cirrhosis and liver cancer in sub-Saharan Africa. To reduce mortality, antiviral treatment programs are needed. We estimated prevalence, vaccine impact, and need for antiviral treatment in Blantyre, Mala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ed0cf64f2b1dc4c3571a2ab7e54a7d
https://researchonline.lshtm.ac.uk/id/eprint/4667297/1/Stockdale_etal_2021_Hepatitis-b-vaccination-impact-and.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4667297/1/Stockdale_etal_2021_Hepatitis-b-vaccination-impact-and.pdf
Autor:
Niza M Silungwe, Alexander J. Stockdale, Isaac Thom Shawa, Benno Kreuels, Anna Maria Geretti, Melita A. Gordon
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Background The World Health Organization (WHO) has targeted a reduction in viral hepatitis-related mortality by 65% and incidence by 90% by 2030, necessitating enhanced hepatitis B treatment and prevention programmes in low- and middle-income countri